BioCentury
ARTICLE | Clinical News

Vfend voriconazole regulatory update

March 25, 2002 8:00 AM UTC

Europe granted marketing approval for PFE's oral and intravenous formulations of Vfend to treat life-threatening fungal infections. The product, a second generation triazole ergosterol synthesis inhi...